Literature DB >> 17449970

(Non-)compliance with guidelines for the management of severe acute pancreatitis among German surgeons.

T Foitzik1, E Klar.   

Abstract

BACKGROUND: Implementation of guidelines for the therapy of acute pancreatitis (e.g. those of the International Association of Pancreatology, IAP) into clinical practice has been assumed but not been evaluated. AIM: To verify the knowledge and acceptance of guidelines for the management of severe acute pancreatitis among German surgeons.
METHODS: A questionnaire consisting of five short questions concerning key points in the management of severe acute pancreatitis was sent to the chairmen of the departments of general and visceral surgery of 39 university and 316 non-university hospitals in Germany. An additional, more detailed questionnaire accompanied the audit of the university chairmen.
RESULTS: The response rate was 62%. 11% stated that they strictly followed all guidelines (IAP recommendations No. 2-6), 31% followed all but one recommendation, 31% did not follow 2 or more of the guidelines, and the answers of 27% suggested that their treatment differed substantially from the guideline recommendations. For example, fine needle aspiration biopsy, recommended to differentiate between infected and sterile necrosis in patients with signs of sepsis, was not performed by 55%, and prophylactic antibiotics, recommended to prevent secondary infection of pancreatic necrosis, were not given by 20%.
CONCLUSION: German surgeons know the IAP recommendations for the management of severe acute pancreatitis and have implemented these guidelines in clinical practice. This, however, does not mean that all guideline concepts are strictly followed.

Entities:  

Mesh:

Year:  2007        PMID: 17449970     DOI: 10.1159/000101882

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  7 in total

1.  Are there too many practice guidelines for acute pancreatitis?

Authors:  Chris E Forsmark
Journal:  Curr Gastroenterol Rep       Date:  2008-08

2.  Failure to follow evidence-based best practice guidelines in the treatment of severe acute pancreatitis.

Authors:  Adrian C Vlada; Bradley Schmit; Andrew Perry; Jose G Trevino; Kevin E Behrns; Steven J Hughes
Journal:  HPB (Oxford)       Date:  2013-10       Impact factor: 3.647

3.  Compliance with Evidence-Based Guidelines in Acute Pancreatitis: an Audit of Practices in University of Toronto Hospitals.

Authors:  J A Greenberg; J Hsu; M Bawazeer; J Marshall; J O Friedrich; A Nathens; N Coburn; H Huang; R S McLeod
Journal:  J Gastrointest Surg       Date:  2015-11-30       Impact factor: 3.452

4.  Surgical management of acute pancreatitis in Italy: lessons from a prospective multicentre study.

Authors:  Paolo De Rai; Alessandro Zerbi; Laura Castoldi; Claudio Bassi; Luca Frulloni; Generoso Uomo; Armando Gabbrielli; Raffaele Pezzilli; Giorgio Cavallini; Valerio Di Carlo
Journal:  HPB (Oxford)       Date:  2010-09-02       Impact factor: 3.647

5.  A combined paging alert and web-based instrument alters clinician behavior and shortens hospital length of stay in acute pancreatitis.

Authors:  Matthew J Dimagno; Erik-Jan Wamsteker; Rafat S Rizk; Joshua P Spaete; Suraj Gupta; Tanya Sahay; Jeffrey Costanzo; John M Inadomi; Lena M Napolitano; Robert C Hyzy; Jeff S Desmond
Journal:  Am J Gastroenterol       Date:  2014-03       Impact factor: 10.864

6.  Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents.

Authors:  Yvonne Tse; David Armstrong; Christopher N Andrews; Alain Bitton; Brian Bressler; John Marshall; Louis W C Liu
Journal:  Can J Gastroenterol Hepatol       Date:  2017-02-08

Review 7.  Clinical practice guideline: management of acute pancreatitis.

Authors:  Joshua A Greenberg; Jonathan Hsu; Mohammad Bawazeer; John Marshall; Jan O Friedrich; Avery Nathens; Natalie Coburn; Gary R May; Emily Pearsall; Robin S McLeod
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.